Paranoia is the unfounded belief that others intend to cause you harm, characterized by excessive suspicion and mistrust despite a lack of evidence. Paranoia, or persecutory ideation, occurs when a person believes they are under intentional threat of harm from others. While mild paranoid thoughts are relatively common in everyday life, persistent paranoia can significantly impact mental health and daily functioning.
While paranoid delusions are often cited as the most commonly experienced form of delusional thinking within clinical populations, substantial evidence suggests that paranoid thinking commonly occurs in the general population. Understanding paranoia—its causes, symptoms, and available treatments—is essential for both those experiencing these thoughts and the professionals who support them.
Table of Contents
- What Is Paranoia?
- Prevalence and Common Experiences
- Signs and Symptoms
- When Paranoia Becomes a Concern
- Causes and Risk Factors
- The Sleep-Paranoia Connection
- Conditions Associated with Paranoia
- Treatment Options
- Frequently Asked Questions
- How Therapy Can Help
- References
What Is Paranoia?
Paranoia involves persistent beliefs that others are trying to harm, deceive, or conspire against you without sufficient evidence to support these concerns. A number of psychosocial models have been proposed that place varying emphasis on the importance of developmental, cognitive, behavioural, affective, and interpersonal factors involved in the formation and maintenance of persecutory beliefs.
People experiencing paranoia may hold one or more of these common beliefs:
- Others are deliberately deceiving or betraying them
- People are communicating threats through subtle hints, gestures, or coded language
- They are being monitored or watched by others
- External forces are controlling their thoughts or actions
- Strangers, acquaintances, or even loved ones harbor malicious intentions
Prevalence and Common Experiences
23.4% of U.S. adults experienced mental illness in 2024 (61.5 million people). While specific paranoia prevalence varies, research indicates it exists on a continuum from mild suspicion to severe persecutory delusions.
A 'hierarchy of paranoia' has been reported within the general population, with a greater proportion of people experiencing slight mistrust and suspicious thoughts at the bottom of the hierarchy, to smaller numbers experiencing persecutory beliefs at the top.
The term 'pandemic paranoia' has been coined to refer to heightened levels of mistrust and suspicion towards other people specifically due to the COVID-19 pandemic.
Signs and Symptoms
Paranoid thinking manifests in various ways, ranging from mild to severe:
Cognitive Symptoms
- Persistent suspicion of others' motives
- Difficulty trusting friends, family, or colleagues
- Furthermore, individuals with elevated vulnerability to paranoia interpret ambiguous environmental information more negatively than those with low vulnerability, a cognitive phenomenon called interpretation bias.
- Hypervigilance to perceived threats
- Tendency to perceive neutral events as personally threatening
Behavioral Symptoms
- Social withdrawal and isolation
- Defensive or guarded communication style
- Excessive checking behaviors (locks, devices, surroundings)
- Reluctance to share personal information
- Confrontational responses to perceived slights
Emotional Symptoms
- Persistent anxiety and fear
- Anger or irritability when feeling threatened
- Paranoia, or fears of harm from others, can have a large impact on a person's wellbeing including difficulties with anxiety, low mood, sleep disturbances, and quality of life.
- Feelings of vulnerability or powerlessness
When Paranoia Becomes a Concern
The severity of paranoia is typically assessed by:
- Conviction level: How strongly the person believes their paranoid thoughts despite contradictory evidence
- Preoccupation: How frequently paranoid thoughts occur throughout the day
- Distress: The emotional impact of these thoughts
- Functional impairment: How much paranoia interferes with work, relationships, and daily activities
While there is a growing literature on paranoia induction in nonclinical populations, there have been disproportionately fewer experimental studies conducted with clinical populations, which is a knowledge gap in the literature that should be addressed in future research.
Paranoia becomes clinically significant when it:
- Persists for extended periods (weeks to months)
- Causes significant distress or anxiety
- Impairs social or occupational functioning
- Leads to isolation or relationship problems
- Results in behavioral changes that disrupt daily life
Causes and Risk Factors
Furthermore, in a second meta-analysis, we analyzed separately the correlation between interpretation bias and severity of paranoid symptoms in clinical and nonclinical samples. Research identifies multiple factors contributing to paranoid thinking:
Psychological Factors
- Trauma history: Similarly, Kammerer, Bub, and Lincoln (2021) found the relationship was partially mediated by stress and that the specific content of nightmares was related to the frequency of paranoia, e.g., nightmares about workspace bullying predicted more frequent paranoia.
- Pre-existing mental health conditions: Anxiety and depression can intensify paranoid thinking
- Cognitive biases: SlowMo focuses on fast reasoning processes that are robustly associated with paranoia: the jumping to conclusions bias (forming rapid judgements focused on a small amount of information) and the belief inflexibility bias.
Environmental Factors
- Social isolation and loneliness
- High-stress environments
- Discrimination or persecution experiences
- Urban living in high-crime areas
Biological Factors
- Sleep disruption: Recent research shows significant connections between sleep problems and paranoia
- Neurological conditions: Dementia, Parkinson's disease, or brain injuries
- Substance use: Cannabis, alcohol, stimulants, and withdrawal states
- Genetic predisposition: Family history of psychotic or paranoid disorders
The Sleep-Paranoia Connection
Conclusion: This review for the first time examines the significant relationship between sleep and paranoia individually. Recent meta-analyses reveal important findings:
The literature supports a small-to-moderate association (r = 0.30, 95% CI: 0.16-0.40 for the seven studies using the most robust measures) with significant heterogeneity among studies but no evidence of publication bias.
There is evidence that the relationship is to some extent causal, with sleep disruption leading to increased paranoia, though there is also some evidence of a bi-directional relationship. This means:
- Poor sleep quality can trigger or worsen paranoid thoughts
- Paranoid thoughts can disrupt sleep, creating a vicious cycle
- Negative affect is frequently seen as a mediator of this relationship.
- Addressing sleep problems may help reduce paranoia symptoms
Conditions Associated with Paranoia
The experience of paranoia is associated with psychosis spectrum disorders including schizophrenia. However, paranoia is also experienced across various other mental health disorders.
Paranoia can occur as a symptom of various mental health conditions:
- Schizophrenia spectrum disorders
- Delusional disorder
- Paranoid personality disorder
- Bipolar disorder (particularly during manic episodes)
- Major depressive disorder with psychotic features
- Post-traumatic stress disorder (PTSD)
- Substance-induced psychotic disorder
- Neurocognitive disorders (dementia, delirium)
Treatment Options
Psychological Interventions
Cognitive Behavioral Therapy (CBT)
Clinical practice guidelines often recommend cognitive-behavioral therapy (CBT) as a first-line treatment for both anxiety disorders and OCRDs. CBT for paranoia focuses on:
- Identifying and challenging paranoid thoughts
- Developing alternative interpretations of events
- Behavioral experiments to test beliefs
- Building coping strategies
Digital Therapeutic Innovations
This study aims to test the efficacy and safety of a mobile app version of CBM-pa, called STOP (successful treatment of paranoia).
Cognitive bias modification for paranoia (CBM-pa) comes from a class of interventions that focus on manipulating interpretation bias. Here, we aimed to develop and evaluate new therapy content for CBM-pa for later use in a self-administered digital therapeutic for paranoia called STOP ("Successful Treatment of Paranoia").
Twenty-seven studies met inclusion criteria (n = 3457, 23 assessment and 4 treatment, 2005–2023, most in Europe). Technologies included virtual reality (VR, n = 23), experience sampling methodology (ESM, n = 2), an app (n = 1), and a combination of VR and ESM (n = 1).
Virtual Reality-Based Treatments
Conclusions: Our findings demonstrated that VR-based interventions are effective treatments. Although the use of VR technology is limited for a variety of reasons, such as cost, it improves symptoms in patients with paranoia.
Pharmacological Interventions
Subsequent studies demonstrated that other antipsychotics, for instance, risperidone and olanzapine, were also highly effective. Medications may include:
- Antipsychotic medications: Both first and second-generation antipsychotics
- Antidepressants: When paranoia occurs with depression or anxiety
- Mood stabilizers: For paranoia associated with mood disorders
Most researchers suggest a tailored approach to treatment for each individual. Atypical antipsychotic medications may help with paranoid ideation and anxiety. Atypical (second-generation) antipsychotics are serotonin-dopamine antagonists.
Emerging Treatments
Improvements, with a small effect size of approximately Cohen's d = 0.3, were found for SlowMo in nearly all other secondary outcome measures – well-being, quality of life, worry, and self-concept – at either or both time points, most consistently at the 24-week follow-up.
Research continues to explore innovative approaches including:
- App-based cognitive bias modification
- Virtual reality exposure therapy
- Mindfulness-based interventions
- Sleep-focused treatments
Frequently Asked Questions
How common is paranoia?
While exact prevalence varies, paranoid thoughts exist on a continuum. Mild suspicious thoughts are relatively common, while clinical-level paranoia requiring treatment affects a smaller percentage of the population. Recent research during the COVID-19 pandemic showed increased rates of "pandemic paranoia" globally.
Can paranoia be cured?
With appropriate treatment, many people experience significant improvement in paranoid symptoms. Psychological therapies are found to have a long duration of effect followed by pharmacological therapy and self-help. Most often, booster sessions carried out over a few months would maintain the gains. Treatment effectiveness varies based on underlying causes, severity, and individual factors.
What's the difference between paranoia and reasonable caution?
Reasonable caution is based on realistic assessment of actual risks and evidence. Paranoia involves persistent suspicion despite lack of evidence and often includes beliefs that are highly unlikely or impossible. Context and proportionality are key distinguishing factors.
How does sleep affect paranoia?
Interestingly, a significant negative bi-directional relationship was found between sleep quality and paranoia in Meyer and colleagues (Meyer et al., 2022), but not for sleep duration and paranoia as was seen in the studies by Hennig and colleagues. In another study, poor sleep quality predicted higher paranoia the following morning (mediated by negative affect) but did not find a relationship in the other direction, with evening paranoia not predicting sleep quality that night.
When should I seek professional help?
Consider seeking help if paranoid thoughts:
- Persist for more than a few weeks
- Cause significant distress
- Interfere with relationships or daily activities
- Lead to isolation or avoidance behaviors
- Are accompanied by other concerning symptoms
Can medication help with paranoia?
The findings were that DD, schizophrenia, and related disorders all presented similar dysregulated mechanisms of dopamine synthesis, which implies that treatment with dopamine antagonists should affect all psychotic diagnostic categories to the same degree, at least if the blockade of dopamine synthesis is the main mechanism of action. Medications can be effective, particularly when paranoia is part of a broader mental health condition.
How Therapy Can Help
Professional therapy provides a safe, confidential environment to explore and address paranoid thoughts. Therapists experienced in treating paranoia can help you:
- Develop insight into thought patterns
- Learn evidence-based coping strategies
- Address underlying trauma or stress
- Improve sleep and reduce anxiety
- Rebuild trust and social connections
- Create a personalized treatment plan
However, treatment with medications and CBT may help individuals manage their symptoms. People with paranoid personality disorder typically hold a strong mistrust of others, meaning treatment may be more difficult. Therapists may begin by recognizing any validity in the individual's suspicions. This can help build a bond between the therapist and the individual, making CBT more effective.
Find Support Today
If paranoid thoughts are affecting your life, you don't have to face them alone. Experienced mental health professionals can provide effective, evidence-based treatment tailored to your specific needs.
Search our directory to find a therapist who specializes in treating paranoia and related concerns. Many therapists offer both in-person and online sessions to accommodate your preferences and needs.
References:
- American Psychiatric Association. (2023). The American Psychiatric Association practice guideline for the treatment of patients with borderline personality disorder. American Journal of Psychiatry, 180(12), 1052-1065. https://doi.org/10.1176/appi.ajp.24181010
- Bajouco, M., Mota, D., Coroa, M., Caldeira, S., Santos, V., Madeira, A., ... & Ribeiro, Ó. (2022). Seventy years of treating delusional disorder with antipsychotics: A historical perspective. Journal of Clinical Medicine, 11(24), 7289. https://doi.org/10.3390/jcm11247289
- Bird, M., O'Neill, E., & Riches, S. (2024). Digitally enhanced psychological assessment and treatment of paranoia: A systematic review. Clinical Psychology & Psychotherapy, 31(4), e3019. https://doi.org/10.1002/cpp.3019
- Brown, P., Reeve, S., Hotton, M., Steer, N., & Steel, C. (2024). Sleep and paranoia: A systematic review and meta-analysis. Clinical Psychology Review, 114, 102503. https://doi.org/10.1016/j.cpr.2024.102503
- Centers for Disease Control and Prevention. (2024). Mental health data channel. U.S. Department of Health and Human Services. https://www.cdc.gov/mental-health/about-data/index.html
- Ellett, L., Varese, F., Owens, J., Rafiq, S., Penn, G., & Berry, K. (2023). Experimental studies of paranoid thinking in clinical and nonclinical populations: A systematic review and meta-analysis. Psychological Medicine, 53(13), 5945-5959. https://doi.org/10.1017/S0033291722001702
- Garety, P., Ward, T., Emsley, R., Greenwood, K., Freeman, D., Fowler, D., ... & Hardy, A. (2021). Digitally supported CBT to reduce paranoia and improve reasoning for people with schizophrenia-spectrum psychosis: The SlowMo RCT. Health Technology Assessment, 25(4), 1-90. https://doi.org/10.3310/hta25040
- Hsu, C. W., Stahl, D., Mouchlianitis, E., Peters, E., Vamvakas, G., Keppens, J., ... & Yiend, J. (2023). User-centered development of STOP (Successful Treatment for Paranoia): Material development and usability testing for a digital therapeutic for paranoia. JMIR Human Factors, 10, e45453. https://doi.org/10.2196/45453
- Lam, D., Adetula, A., McCarthy, P., & McGuire, P. (2022). Pandemic paranoia in the general population: International prevalence and sociodemographic profile. Psychological Medicine, 53(10), 4388-4398. https://doi.org/10.1017/S0033291722002380
- Manickam, L. S. S., Sathyanarayana Rao, T. S., & Sharan, P. (2020). Clinical practice guidelines for cognitive-behavioral therapies in anxiety disorders and obsessive-compulsive and related disorders. Indian Journal of Psychiatry, 62(Suppl 2), S230-S250. https://doi.org/10.4103/psychiatry.IndianJPsychiatry_774_19
- National Alliance on Mental Illness. (2024). Mental health by the numbers. https://www.nami.org/about-mental-illness/mental-health-by-the-numbers/
- National Institute of Mental Health. (2025). Panic disorder: What you need to know. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/publications/panic-disorder-when-fear-overwhelms
- Steel, C., Hardy, A., Smith, B., Wykes, T., Rose, S., Enright, S., ... & Mueser, K. T. (2023). Assessing the efficacy and safety of STOP (successful treatment for paranoia)—an app-based cognitive bias modification therapy for paranoia: A randomised clinical trial protocol. Trials, 24(1), 780. https://doi.org/10.1186/s13063-024-08570-3
- Substance Abuse and Mental Health Services Administration. (2024). National Survey on Drug Use and Health 2024 releases. U.S. Department of Health and Human Services. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health/national-releases/2024
- Trotta, A., Kang, J., Stahl, D., & Yiend, J. (2021). Interpretation bias in paranoia: A systematic review and meta-analysis. Clinical Psychological Science, 9(1), 3-23. https://doi.org/10.1177/2167702620951552
